Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Amee Patel"'
Autor:
Curt Ekström
Publikováno v:
Upsala Journal of Medical Sciences, Vol 126, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/8de1ef0bdbea45469b286c1f10e7dbb8
Autor:
Ekström C; Department of Neuroscience, Ophthalmology, Uppsala University, Uppsala, Sweden. http://orcid.org/0000-0002-8265-6518.
Publikováno v:
Upsala journal of medical sciences [Ups J Med Sci] 2021 Dec 31; Vol. 126. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2021).
Autor:
Mai Fujiwara, Radhika Raheja, Lucien P. Garo, Amrendra K. Ajay, Ryoko Kadowaki-Saga, Sukrut H. Karandikar, Galina Gabriely, Rajesh Krishnan, Vanessa Beynon, Anu Paul, Amee Patel, Shrishti Saxena, Dan Hu, Brian C. Healy, Tanuja Chitnis, Roopali Gandhi, Howard L. Weiner, Gopal Murugaiyan
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 10 (2022)
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17–producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS au
Externí odkaz:
https://doaj.org/article/f89dcb7cef1c42e89481250a5cdf5db1
Autor:
Galina Gabriely, Duanduan Ma, Shafiuddin Siddiqui, Linqing Sun, Nathaniel P. Skillin, Hadi Abou-El-Hassan, Thais G. Moreira, Dustin Donnelly, Andre P. da Cunha, Mai Fujiwara, Lena R. Walton, Amee Patel, Rajesh Krishnan, Stuart S. Levine, Brian C. Healy, Rafael M. Rezende, Gopal Murugaiyan, Howard L. Weiner
Publikováno v:
iScience, Vol 24, Iss 11, Pp 103347- (2021)
Summary: Myeloid suppressor cells promote tumor growth by a variety of mechanisms which are not fully characterized. We identified myeloid cells (MCs) expressing the latency-associated peptide (LAP) of TGF-β on their surface and LAPHi MCs that stimu
Externí odkaz:
https://doaj.org/article/cd2b4250e05d4e979dda9bd8430b32ec
Autor:
Amee Patel, Krish Patel
Publikováno v:
Upsala Journal of Medical Sciences, Vol 126, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/46b0bd12e3824d06b18d77501e88169d
Autor:
Sandeep S. Dave, Dereje D. Jima, Anne Beaven, Jason Smith, Amee Patel, Alice Fan, Qingquan Liu, Cassandra Love, Matthew S. McKinney, Katherine Walsh
PDF file - 80 KB, Supplementary Table S1 lists the cell lines and their respective IC50s for all three of the PI3K inhibitors evaluated in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138ad5a52e0b030e9f67abc1767f88ec
https://doi.org/10.1158/1078-0432.22449239
https://doi.org/10.1158/1078-0432.22449239
Autor:
Sandeep S. Dave, Dereje D. Jima, Anne Beaven, Jason Smith, Amee Patel, Alice Fan, Qingquan Liu, Cassandra Love, Matthew S. McKinney, Katherine Walsh
PDF file - 72 KB, Supplementary Figure S1 shows the results for the experiment to determine if there was a therapeutic window between malignant and normal cells. Both IPA-3 and BEZ235 individually and in combination were selectively toxic to malignan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c49d0b4ccab603b8551dcf8a38d6ea1
https://doi.org/10.1158/1078-0432.22449245.v1
https://doi.org/10.1158/1078-0432.22449245.v1
Autor:
Sandeep S. Dave, Dereje D. Jima, Anne Beaven, Jason Smith, Amee Patel, Alice Fan, Qingquan Liu, Cassandra Love, Matthew S. McKinney, Katherine Walsh
Purpose: The phosphoinositide 3-kinase (PI3K) pathway is known to play an active role in many malignancies. The role of PI3K inhibition in the treatment of lymphomas has not been fully delineated. We sought to identify a role for therapeutic PI3K inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1192bd6fe32e533f3ecc079bfa0be0
https://doi.org/10.1158/1078-0432.c.6521591.v1
https://doi.org/10.1158/1078-0432.c.6521591.v1
Autor:
Sandeep S. Dave, Dereje D. Jima, Anne Beaven, Jason Smith, Amee Patel, Alice Fan, Qingquan Liu, Cassandra Love, Matthew S. McKinney, Katherine Walsh
PDF file - 38 KB, The Supplementary Data Legend provides the legends for Supplementary Table S1 and Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4904f3d8bfae0738ab2ce6219067f75c
https://doi.org/10.1158/1078-0432.22449242.v1
https://doi.org/10.1158/1078-0432.22449242.v1
Autor:
Anil Handoo, Vipin Khandelwal, Tina Dadu, Rasika Setia, Dharma Choudhary, Amee Patel, Sanjeev Sharma, Divya Doval
Publikováno v:
Indian J Hematol Blood Transfus
The conditioning regimens used for the allo-HSCT include either myeloablative conditioning (MAC) or reduced intensity conditioning (RIC) regimens based on the age, performance status and co-morbidities. Studies comparing the survival outcomes of RIC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4999094ffdaaec2de6e47c183accd35e
https://doi.org/10.1007/s12288-020-01386-6
https://doi.org/10.1007/s12288-020-01386-6